DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Castro M, Zangrilli J, Wechsler ME. et al.
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.
Lancet Respir Med 2015;
3: 355-366
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.